Biotherapy Development Association (BDA) Paediatric Oncology Workshop

London, United Kingdom

5-6 December 2011

The goal of the Biotherapy Development Association (BDA) Paediatric Oncology Workshop was to provide an action plan to increase the likelihood of children and adolescents with cancer benefitting from both the EU Paediatric Medicines Regulation (Regulation (EC) No 1901/2006) and EU-funded structuring activities.

Representatives from academia, the pharmaceutical industry, the European Medicine Agency (EMA), the EMA Paediatric Committee, Government bodies, Members of the European Parliament (MEPs) as well as parents and patients attended the meeting to discover the recent advances in the field of paediatric oncology.

This critical evaluation of the impact of the EU and US regulations on paediatric oncology is really relevant with a view to proposing solutions to identified bottlenecks and hurdles.

View the event programme.

For further information on the event, please contact the BDA Oncology Secretariat at: bdaoncology<at>il.nl (please replace <at> with @) or tel.: +31 299 413 005.